Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12
Closed -$452 497
2023
Q4
$452 Sell
12
-4
-25% -$122 ﹤0.01% 448
2023
Q3
$445 Hold
16
﹤0.01% 467
2023
Q2
$484 Buy
+16
New +$468 ﹤0.01% 463
2022
Q2
Sell
-118
Closed -$6K 415
2022
Q1
$6K Sell
118
-18
-13% -$911 ﹤0.01% 336
2021
Q4
$7K Sell
136
-7
-5% -$331 ﹤0.01% 338
2021
Q3
$6K Buy
143
+70
+96% +$2.96K ﹤0.01% 242
2021
Q2
$3K Buy
73
+37
+103% +$1.74K ﹤0.01% 246
2021
Q1
$2K Buy
+36
New +$1.51K ﹤0.01% 341

Other funds holding SNV

Denali Advisors's SNV Position: Q1 2024 in Review

Denali Advisors sold out of Synovus (SNV) in Q1 2024, closing a stake of 12 shares — an estimated $452 sold.

Denali Advisors first reported a position in SNV in Q1 2021 and held it in 8 quarters. The position peaked at $7K in Q4 2021. 408 funds tracked by Wall St. Rank hold SNV as of Q1 2024.

  • Denali Advisors reported no remaining Synovus position as of Q1 2024 after selling out during the quarter.
  • Denali Advisors sold 12 Synovus shares in Q1 2024, an estimated $452.
  • Denali Advisors first reported a position in Synovus in Q1 2021 and held it in 8 quarters.
  • Denali Advisors's Synovus position peaked at $7K in Q4 2021.
  • 408 funds tracked by Wall St. Rank held Synovus as of Q1 2024.

Based on Denali Advisors's 13F filing for Q1 2024, filed 19 Apr 2024.